Rhein Laser Announces FDA 510(k) Clearance of UroFiber 60Q

December 05, 2024 01:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

The Most Powerful Thulium SuperPulsed Fiber Laser for Urology is Here

WUHAN, China, Dec. 4, 2024 /PRNewswire/ -- Rhein Laser Technologies Co., Ltd. is proud to announce that its UroFiber® 60Q SuperPulsed Thulium Fiber Laser System received FDA 510(k) clearance (K242293) on November 19, 2024, marking a significant breakthrough in surgical laser development. This certification makes Rhein Laser the first Chinese company to gain FDA clearance for a thulium fiber laser, demonstrating that its products meet the highest global standards set by the U.S. FDA, further reinforcing the company's leadership in medical laser technology.

Rhein Laser Announces FDA 510(k) Clearance of UroFiber 60Q The Most Powerful Thulium SuperPulsed Fiber Laser for Urology is Here
Rhein Laser Announces FDA 510(k) Clearance of UroFiber 60Q The Most Powerful Thulium SuperPulsed Fiber Laser for Urology is Here

UroFiber 60Q offers clear technological advantages. Compared to other fiber lasers, it delivers 20% higher laser peak power and 15% higher average output laser power, significantly enhancing performance, precision, and treatment speed. In laser lithotripsy, its increased power allows for rapid stone fragmentation, reducing treatment time and minimizing collateral damage, leading to faster patient recovery. In soft tissue treatments, the laser's precision reduces bleeding, minimizes thermal damage, and shortens recovery time, offering a safer, more effective treatment experience for patients.

The FDA clearance of UroFiber 60Q not only validates its safety and effectiveness but also opens up new opportunities for Rhein Laser to expand its reach in the U.S. and global markets. As the first Chinese company to achieve FDA clearance for thulium fiber laser technology, Rhein Laser is poised to bring its innovative solutions to a wider audience and continue driving advancements in medical treatments worldwide.

In addition, Rhein Laser is advancing further with the UroFiber 150Q, a powerful water-cooled system for which FDA clearance has already been submitted. UroFiber 150Q features 10J single-laser pulse energy with 200um application fiber, a 15Hz repetition frequency, and 150W maximum pulse output laser power, making it the most powerful SuperPulsed thulium fiber laser available. With these advanced specifications, UroFiber 150Q will offer even faster, more effective treatments, positioning it as the future leader in urological laser therapy.

"We have strong R&D teams based in Duesseldorf and in Wuhan of China's Optics Valley, combining Germany's precision with China's innovative efficiency, which allows us to continuously push the boundaries of laser technology," said Dr. Lin Yang, CEO of Rhein Laser. "Our goal is to provide world-class medical laser solutions and improve patient outcomes globally."

With FDA certification and cutting-edge technology, UroFiber 60Q is set to lead the future of urological laser treatments, delivering enhanced safety, precision, and patient care that will transform medical practices worldwide.

For more information
Visit www.UroFiber.com for more details about the UroFiber laser system.

Media Contact:
[email protected] 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.